edgewise Archives

Here’s What You Missed at the MDA Clinical and Scientific Conference

March 7, 2024

Here’s What You Missed at the MDA Clinical and Scientific Conference 2024

Edgewise Therapeutics Announces Initiation of GRAND CANYON, a Global Pivotal Study of EDG-5506 in Becker Muscular Dystrophy (Becker)

September 26, 2023

– GRAND CANYON is the first pivotal study of an investigational therapy for Becker–– CANYON, the initial Phase 2 cohorts, is fully enrolled – BOULDER, Colo.–(BUSINESS WIRE)– Edgewise Therapeutics, Inc. (Nasdaq: […]

A Novel Approach to Protect Muscle in Duchenne and Becker Muscular Dystrophy

November 3, 2022

Join Edgewise Chief Scientific Officer and Chief Medical Officer to learn more about the clinical development program for EDG-5506, a myosin modulator, in Becker and Duchenne muscular dystrophies. The presentation […]

Edgewise Begins New Observational Trial

April 14, 2022

We are pleased to share that Edgewise Therapeutics is sponsoring a natural history study in Becker muscular dystrophy, to better understand the course of disease and define endpoints to be […]